Do you want to read an article? Please log in or register.
Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study
Pulmonary Fibrosis
RECOMMENDED
Related content
COMMENTED
Inhaled mannitol for cystic fibrosis
Cochrane Database Syst Rev.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
doi: 10.1002/14651858.
RECOMMENDED
Bronchi
Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Martínez-García MÁ, Oscullo G, Barreiro E, Cuenca S, Cervera A, Padilla-Galo A, de la Rosa D, Navarro A, Giron R, Carbonero F, Castro Otero M, Casas F
doi: 10.3390/jcm9072317.
RECOMMENDED
Pulmonary Fibrosis
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Konstan MW, VanDevanter DR, Rowe SM, Wilschanski M, Kerem E, Sermet-Gaudelus I, DiMango E, Melotti P, McIntosh J, De Boeck K, ACT CF Study Group
doi: 10.1016/j.jcf.2020.01.007.
RECOMMENDED
Asthma
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma
J Pharmacol Exp Ther.
Khindri S, Cahn A, Begg M, Montembault M, Leemereise C, Cui Y, Hogg A, Wajdner H, Yang S, Robertson J, Hamblin JN, Ludwig-Sengpiel A, Kornmann O, Hessel EM
doi: 10.1124/jpet.118.249516.
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial
Lancet Respir Med.
Ratjen F, Hug C, Marigowda G, Tian S, Huang X, Stanojevic S, Milla CE, Robinson PD, Waltz D, Davies JC; VX14-809-109 investigator group
doi: 10.1016/
Pulmonary Fibrosis
Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study
Curr Med Res Opin.
Sommerwerck U, Virella-Lowell I, Angyalosi G, Viegas A, Cao W, Debonnett L
doi: 10.1080/
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.
RECOMMENDED
Bronchi
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Lancet Respir Med.
Laska IF, Crichton ML, Shoemark A, Chalmers JD
doi: 10.1016/S2213-2600
RECOMMENDED
Pulmonary Fibrosis
Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Chilvers MA, Davies JC, Milla C, Tian S, Han Z, Cornell AG, Owen CA, Ratjen F
doi: 10.1016/S2213-2600(20)30517-8